查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1534949

3D心臟定位系统市场:现状分析与预测(2024-2032年)

3D Cardiac Mapping System Market: Current Analysis and Forecast (2024-2032)
出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 131 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

3D心臟测绘系统市场预计将呈现约10%的成长率。这主要是由于心血管併发症的增加，由于越来越多的患者需要改进的诊断和治疗方案，这也将扩大 3D 心臟绘图系统市场。此外，这些公司还致力于研究和开髮用于心臟医疗应用的新绘图技术，并为患者、客户和医护人员提供有效使用这些先进心臟绘图系统的指导。的认识。例如，2022年4月，飞利浦在2022年欧洲心律协会年会上展示了其最新的KODEX-EPD心臟测绘和导航系统。

同样在 2021 年 6 月，美国医疗创新公司 Cardiac Insights, Inc. 在 2021 年阿拉伯健康大会上推出了 Cardiac SOLO ECG 系统。 Cardea SOLO 将一次性、患者友善穿戴式心电图感测器与 100% 医生管理的诊所自动化软体结合。

依类型划分，市场分为电解剖标测、篮式导管标测和即时位置管理（心臟通路）电生理系统。其中，电解剖测绘透过提供准确的即时心电活动视觉化，预计将在 3D 心臟测绘系统市场中占据最大的市场占有率。这项技术使心臟科医生能够创建心臟电通路的详细解剖图，这可以帮助诊断和治疗心律不整和其他心臟疾病。电解剖测绘能够提高手术效率、减少放射线暴露和改善病患治疗效果，成为扩大 3D 心臟测绘系统全球采用和成长的关键驱动力。

根据应用，市场分为医院和诊所、门诊手术中心等。其中，医院和诊所类别预计将占据3D心臟测绘系统市场的最大市场占有率。这是因为心血管疾病在医疗机构中变得越来越常见，而此类机构持续需要准确且高效的心臟测绘系统。透过实施这种 3D 心臟测绘系统，医院和诊所可以轻鬆提高诊断效果，提高病患满意度和治疗效率。这些医院和诊所不仅将提高3D心臟测绘系统的采用和使用率，而且还将透过不断创新积极推动市场成长，并使3D心臟测绘系统成为心臟治疗的主流，这就是我们大力投资新型和心臟治疗的原因。

为了更了解 3D 心臟绘图系统的市场介绍，市场分为北美（美国、加拿大、欧洲其他地区）、欧洲（德国、英国、法国、西班牙、义大利、欧洲其他地区）、亚洲太平洋地区（根据其他地区（中国、日本、印度、亚太其他地区）和其他地区的全球影响力进行分析。北美 3D 心臟测绘系统市场是指开发心臟电特性的全面且增强的几何表示的技术解决方案的消费。推动这一市场的因素包括心律不整和其他疾病病例的增加、微创手术的成长趋势以及测绘系统技术的快速成长。主要驱动因素包括测绘技术进步，以提高未来的准确性、更好的卫生系统、物联网和医疗设备资讯提供和提供者关係、深化市场和提高人们的护理品质等。

市场上的主要公司包括雅培 (Abbott)、Acutus Medical, Inc.、BioSig Technologies, Inc.、Boston Scientific Corporation、Johnson & Johnson Services, Inc.、美敦力。

目录

第1章 市场简介

  • 市场定义
  • 主要目的
  • 相关利益者
  • 限制事项

第2章 调查手法或前提条件

  • 调查流程
  • 调查手法
  • 受访者简介

第3章 摘要整理

  • 产业摘要
  • 各市场区隔预测
    • 市场成长的强度
  • 地区展望

第4章 市场动态

  • 促进因素
  • 机会
  • 阻碍因素
  • 趋势
  • PESTEL分析
  • 需求面分析
  • 供给面分析
    • 合併和收购
    • 投资情势
    • 产业洞察：主要新创公司及其独特策略

第5章 价格分析

  • 各地区价格分析
  • 价格的影响因素

第6章 全球3D心臟定位系统市场收益，2022-2032年

第7章 各类型的市场分析

  • 电力解剖学的製图
  • 桶子导管製图
  • 即时位置管理(心臟途径)EP系统

第8章 各用途的市场分析

  • 医院&诊所
  • 门诊病人手术中心
  • 其他

第9章 各地区的市场分析

  • 北美
    • 美国
    • 加拿大
    • 其他北美地区
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 全球其他地区

第10章 价值链分析

  • 限制分析
  • 市场参与企业一览

第11章 竞争情形

  • 竞争仪表板
  • 竞争市场定位分析
  • 波特的五力分析

第12章 企业简介

  • Abbott
  • Acutus Medical, Inc.
  • APN Health, LLC
  • BioSig Technologies, Inc.
  • Biotronik
  • Boston Scientific Corporation
  • Catheter Precision Inc.
  • Johnson & Johnson Services, Inc.
  • Koninklijke Philips N.V.
  • Medtronic

第13章 缩写与前提条件

第14章 附录

简介目录
Product Code: UMHE212948

The market for 3D cardiac mapping systems is a relatively new and emerging segment of the medical devices market, specializing in the identification and treatment of life-threatening heart diseases. These systems give dynamic and detailed three-dimensional images of the electrical activity of the human heart therefore increasing the accuracy of cardiac procedures. Growth in the market is chiefly due to growth in the incidence of cardiovascular diseases, shifting trends in preference towards fewer invasive surgeries, and continuous innovation in technology used in cardiac mapping systems. Furthermore, a rise in healthcare costs, a rise in the geriatric population, as well as government support for the same makes the market more conducive.

The market for 3D cardiac mapping systems market is set to exhibit a growth rate of about 10%. This is mainly due to the rise of cardiovascular complications, which also increases the market for a 3D cardiac mapping system for patients, as more individuals require improved diagnosis and treatment options. Furthermore, the companies are engaged in R&D to develop new mapping techniques for cardiac medical applications and focus on expanding awareness of activities most relevant to patients, customers, and healthcare personnel for the effective use of these advanced cardiac mapping systems worldwide. For instance, in April 2022, Philips showcased its latest KODEX-EPD cardiac mapping and navigation system at the 2022 European Heart Rhythm Association annual meeting.

Also, in June 2021, Cardiac Insights, Inc., a United States-based healthcare innovator, launched its Cardea SOLO ECG System at Arab Health 2021. Cardea SOLO combines a single-use, patient-friendly wearable ECG sensor with 100% in-clinic automated software administered by physicians.

Based on type, the market is segmented into electroanatomical mapping, basket catheter mapping, and real-time positional management (cardiac pathways) EP system. Among these, electroanatomical mapping is expected to have the largest market share of the 3D cardiac mapping system market by offering precise, real-time visualization of cardiac electrical activity. This technology enables cardiologists to create detailed anatomical maps of the heart's electrical pathways, aiding in the diagnosis and treatment of arrhythmias and other cardiac conditions. Its ability to enhance procedural efficiency, reduce radiation exposure, and improve patient outcomes positions electroanatomical mapping as a critical driver in expanding the adoption and growth of 3D Cardiac Mapping Systems globally.

Based on the application, the market is segmented into hospitals & clinics, ambulatory surgical centers, and others. Among these, the hospitals & clinics category is expected to have the largest market share of the 3D cardiac mapping systems market due to cardiovascular diseases have become more prevalent in healthcare facilities, and as such, these facilities are continually in need of accurate and efficient cardiac mapping systems. Due to the implementation of these 3D cardiac mapping systems, hospitals, and clinics can easily promote the effectiveness of their diagnosis and increase patient satisfaction and procedural efficiency. They invest heavily in new and advanced medical technology that not only enhances the adoption rates and utilization of 3D cardiac mapping systems but also actively drives the growth of the market through constant innovation and bringing 3D cardiac mapping systems to mainstream cardiac care.

For a better understanding of the market adoption of 3D cardiac mapping systems, the market is analyzed based on its worldwide presence in countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. The North American 3D cardiac mapping system market refers to the consumption of technology solutions through which comprehensive and enhanced geometrical representations of cardiac electrical characteristics are developed. The drivers of this market include growing cases of cardiac arrhythmias and other disorders, growing trends in minimally invasive surgeries, and the existing burgeoning of mapping systems technology. Some of the significant driving forces include advancements in technologies in mapping as a way of enhancing precision in the future, the good healthcare system, and the relationships between the Internet of Things and medical device informing and healthcare providers, deepening the market and improving the quality of care for the people.

Some of the major players operating in the market include Abbott; Acutus Medical, Inc.; APN Health, LLC; BioSig Technologies, Inc.; Biotronik; Boston Scientific Corporation; Catheter Precision Inc.; Johnson & Johnson Services, Inc.; Koninklijke Philips N.V.; and Medtronic.

TABLE OF CONTENTS

1.MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2.RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Global 3D Cardiac Mapping System Market
  • 2.2. Research Methodology of the Global 3D Cardiac Mapping System Market
  • 2.3. Respondent Profile

3.EXECUTIVE SUMMARY

  • 3.1. Industry Synopsis
  • 3.2. Segmental Outlook
    • 3.2.1. Market Growth Intensity
  • 3.3. Regional Outlook

4.MARKET DYNAMICS

  • 4.1. Drivers
  • 4.2. Opportunity
  • 4.3. Restraints
  • 4.4. Trends
  • 4.5. PESTEL Analysis
  • 4.6. Demand Side Analysis
  • 4.7. Supply Side Analysis
    • 4.7.1. Merger & Acquisition
    • 4.7.2. Investment Scenario
    • 4.7.3. Industry Insights: Leading Startups and Their Unique Strategies

5.PRICING ANALYSIS

  • 5.1. Regional Pricing Analysis
  • 5.2. Price Influencing Factors

6.GLOBAL 3D CARDIAC MAPPING SYSTEM MARKET REVENUE (USD MN), 2022-2032F

7.MARKET INSIGHTS BY TYPE

  • 7.1. Electroanatomical Mapping
  • 7.2. Basket Catheter Mapping
  • 7.3. Real-time positional management (cardiac pathways) EP system

8.MARKET INSIGHTS BY APPLICATION

  • 8.1. Hospitals & Clinics
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Others

9.MARKET INSIGHTS BY REGION

  • 9.1. North America
    • 9.1.1. U.S.
    • 9.1.2. Canada
    • 9.1.3. Rest of North America
  • 9.2. Europe
    • 9.2.1. Germany
    • 9.2.2. U.K.
    • 9.2.3. France
    • 9.2.4. Italy
    • 9.2.5. Spain
    • 9.2.6. Rest of Europe
  • 9.3. Asia-Pacific
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. India
    • 9.3.4. Rest of Asia-Pacific
  • 9.4. Rest of World

10.VALUE CHAIN ANALYSIS

  • 10.1. Marginal Analysis
  • 10.2. List of Market Participants

11.COMPETITIVE LANDSCAPE

  • 11.1. Competition Dashboard
  • 11.2. Competitor Market Positioning Analysis
  • 11.3. Porter Five Forces Analysis

12.COMPANY PROFILED

  • 12.1. Abbott
    • 12.1.1. Company Overview
    • 12.1.2. Key Financials
    • 12.1.3. SWOT Analysis
    • 12.1.4. Product Portfolio
    • 12.1.5. Recent Developments
  • 12.2. Acutus Medical, Inc.
  • 12.3. APN Health, LLC
  • 12.4. BioSig Technologies, Inc.
  • 12.5. Biotronik
  • 12.6. Boston Scientific Corporation
  • 12.7. Catheter Precision Inc.
  • 12.8. Johnson & Johnson Services, Inc.
  • 12.9. Koninklijke Philips N.V.
  • 12.10. Medtronic

13.ACRONYMS & ASSUMPTION

14.ANNEXURE